Ignet

Gene Information

Gene symbol: NR1I2

Gene name: nuclear receptor subfamily 1, group I, member 2

HGNC ID: 7968

Synonyms: ONR1, PXR, BXR, SXR, PAR2

Related Genes

#	Gene Symbol	Number of hits
1	IFNG	1 hits
2	MYH14	1 hits
3	MYLK	1 hits
4	TJP1	1 hits

Related Sentences

#	PMID	Sentence
1	15194744	PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.
2	15194744	PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.
3	15194744	PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.
4	15194744	PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.
5	15194744	We further investigated the possible involvement of interferon gamma (IFN-gamma) and calmodulin-dependent activation of myosin light chain kinase (MLCK), and alterations of zonula occludens-1 (ZO-1) localization in PAR(2)-induced responses.
6	15194744	We further investigated the possible involvement of interferon gamma (IFN-gamma) and calmodulin-dependent activation of myosin light chain kinase (MLCK), and alterations of zonula occludens-1 (ZO-1) localization in PAR(2)-induced responses.
7	15194744	We further investigated the possible involvement of interferon gamma (IFN-gamma) and calmodulin-dependent activation of myosin light chain kinase (MLCK), and alterations of zonula occludens-1 (ZO-1) localization in PAR(2)-induced responses.
8	15194744	We further investigated the possible involvement of interferon gamma (IFN-gamma) and calmodulin-dependent activation of myosin light chain kinase (MLCK), and alterations of zonula occludens-1 (ZO-1) localization in PAR(2)-induced responses.
9	15194744	Western blotting showed phosphorylation of mucosal myosin light chain (MLC) expression after both doses of SLIGRL.
10	15194744	Western blotting showed phosphorylation of mucosal myosin light chain (MLC) expression after both doses of SLIGRL.
11	15194744	Western blotting showed phosphorylation of mucosal myosin light chain (MLC) expression after both doses of SLIGRL.
12	15194744	Western blotting showed phosphorylation of mucosal myosin light chain (MLC) expression after both doses of SLIGRL.
13	15194744	Finally, we have shown that direct activation of PAR(2) on enterocytes is responsible for increased permeability and ZO-1 disruption.
14	15194744	Finally, we have shown that direct activation of PAR(2) on enterocytes is responsible for increased permeability and ZO-1 disruption.
15	15194744	Finally, we have shown that direct activation of PAR(2) on enterocytes is responsible for increased permeability and ZO-1 disruption.
16	15194744	Finally, we have shown that direct activation of PAR(2) on enterocytes is responsible for increased permeability and ZO-1 disruption.
17	15194744	The resulting tight junction opening does not depend upon IFN-gamma secretion, while the increased permeability in response to the high dose of PAR(2) agonist involves IFN-gamma secretion.
18	15194744	The resulting tight junction opening does not depend upon IFN-gamma secretion, while the increased permeability in response to the high dose of PAR(2) agonist involves IFN-gamma secretion.
19	15194744	The resulting tight junction opening does not depend upon IFN-gamma secretion, while the increased permeability in response to the high dose of PAR(2) agonist involves IFN-gamma secretion.
20	15194744	The resulting tight junction opening does not depend upon IFN-gamma secretion, while the increased permeability in response to the high dose of PAR(2) agonist involves IFN-gamma secretion.